Literature DB >> 26103095

Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm.

Jessica E Haberer1, David R Bangsberg, Jared M Baeten, Kathryn Curran, Florence Koechlin, K Rivet Amico, Peter Anderson, Nelly Mugo, Francois Venter, Pedro Goicochea, Carlos Caceres, Kevin O'Reilly.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26103095      PMCID: PMC4480436          DOI: 10.1097/QAD.0000000000000647

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  40 in total

1.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Authors:  Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden
Journal:  N Engl J Med       Date:  2010-11-23       Impact factor: 91.245

2.  HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial.

Authors:  Susan P Buchbinder; David V Glidden; Albert Y Liu; Vanessa McMahan; Juan V Guanira; Kenneth H Mayer; Pedro Goicochea; Robert M Grant
Journal:  Lancet Infect Dis       Date:  2014-03-07       Impact factor: 25.071

3.  Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission.

Authors:  Kristine B Patterson; Heather A Prince; Eric Kraft; Amanda J Jenkins; Nicholas J Shaheen; James F Rooney; Myron S Cohen; Angela D M Kashuba
Journal:  Sci Transl Med       Date:  2011-12-07       Impact factor: 17.956

4.  Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention.

Authors:  Ariane van der Straten; Lut Van Damme; Jessica E Haberer; David R Bangsberg
Journal:  AIDS       Date:  2012-04-24       Impact factor: 4.177

5.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.

Authors:  Michael C Thigpen; Poloko M Kebaabetswe; Lynn A Paxton; Dawn K Smith; Charles E Rose; Tebogo M Segolodi; Faith L Henderson; Sonal R Pathak; Fatma A Soud; Kata L Chillag; Rodreck Mutanhaurwa; Lovemore Ian Chirwa; Michael Kasonde; Daniel Abebe; Evans Buliva; Roman J Gvetadze; Sandra Johnson; Thom Sukalac; Vasavi T Thomas; Clyde Hart; Jeffrey A Johnson; C Kevin Malotte; Craig W Hendrix; John T Brooks
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

6.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Authors:  Jared M Baeten; Deborah Donnell; Patrick Ndase; Nelly R Mugo; James D Campbell; Jonathan Wangisi; Jordan W Tappero; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Edwin Were; Kenneth H Fife; James Kiarie; Carey Farquhar; Grace John-Stewart; Aloysious Kakia; Josephine Odoyo; Akasiima Mucunguzi; Edith Nakku-Joloba; Rogers Twesigye; Kenneth Ngure; Cosmas Apaka; Harrison Tamooh; Fridah Gabona; Andrew Mujugira; Dana Panteleeff; Katherine K Thomas; Lara Kidoguchi; Meighan Krows; Jennifer Revall; Susan Morrison; Harald Haugen; Mira Emmanuel-Ogier; Lisa Ondrejcek; Robert W Coombs; Lisa Frenkel; Craig Hendrix; Namandjé N Bumpus; David Bangsberg; Jessica E Haberer; Wendy S Stevens; Jairam R Lingappa; Connie Celum
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

7.  Single dose pharmacokinetics of oral tenofovir in plasma, peripheral blood mononuclear cells, colonic tissue, and vaginal tissue.

Authors:  Nicolette A Louissaint; Ying-Jun Cao; Paul L Skipper; Rosa G Liberman; Steven R Tannenbaum; Sridhar Nimmagadda; Jean R Anderson; Stephanie Everts; Rahul Bakshi; Edward J Fuchs; Craig W Hendrix
Journal:  AIDS Res Hum Retroviruses       Date:  2013-05-29       Impact factor: 2.205

8.  Realtime adherence monitoring of antiretroviral therapy among HIV-infected adults and children in rural Uganda.

Authors:  Jessica E Haberer; Julius Kiwanuka; Denis Nansera; Conrad Muzoora; Peter W Hunt; Jacquelyn So; Michael O'Donnell; Mark Siedner; Jeffrey N Martin; David R Bangsberg
Journal:  AIDS       Date:  2013-08-24       Impact factor: 4.177

9.  Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers.

Authors:  Gaudensia Mutua; Eduard Sanders; Peter Mugo; Omu Anzala; Jessica E Haberer; David Bangsberg; Burc Barin; James F Rooney; David Mark; Paramesh Chetty; Patricia Fast; Frances H Priddy
Journal:  PLoS One       Date:  2012-04-12       Impact factor: 3.240

10.  Adherence to preexposure prophylaxis: current, emerging, and anticipated bases of evidence.

Authors:  K Rivet Amico; Michael J Stirratt
Journal:  Clin Infect Dis       Date:  2014-07       Impact factor: 9.079

View more
  136 in total

1.  Hypo-osmolar Formulation of Tenofovir (TFV) Enema Promotes Uptake and Metabolism of TFV in Tissues, Leading to Prevention of SHIV/SIV Infection.

Authors:  Peng Xiao; Sanjeev Gumber; Mark A Marzinke; Abhijit A Date; Thuy Hoang; Justin Hanes; Laura M Ensign; Lin Wang; Lisa Rohan; Edward J Fuchs; Craig Hendrix; Francois Villinger
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

2.  Short Message Service (SMS) Surveys Assessing Pre-exposure Prophylaxis (PrEP) Adherence and Sexual Behavior are Highly Acceptable Among HIV-Uninfected Members of Serodiscordant Couples in East Africa: A Mixed Methods Study.

Authors:  Timothy R Muwonge; Kenneth Ngure; Elly Katabira; Nelly Mugo; Grace Kimemia; Bridget Frances O'Rourke Burns; Nicholas Musinguzi; Felix Bambia; Jared M Baeten; Renee Heffron; Jessica E Haberer
Journal:  AIDS Behav       Date:  2019-05

3.  Preexposure Prophylaxis Monitoring in New York City: A Public Health Approach.

Authors:  Julie E Myers; Zoe R Edelstein; Demetre C Daskalakis; Anisha D Gandhi; Kavita Misra; Alexis V Rivera; Paul M Salcuni; Kathleen Scanlin; Chi-Chi Udeagu; Sarah L Braunstein
Journal:  Am J Public Health       Date:  2018-11       Impact factor: 9.308

4.  Urine assay for tenofovir to monitor adherence in real time to tenofovir disoproxil fumarate/emtricitabine as pre-exposure prophylaxis.

Authors:  H C Koenig; K Mounzer; G W Daughtridge; C E Sloan; L Lalley-Chareczko; G S Moorthy; S C Conyngham; A F Zuppa; L J Montaner; P Tebas
Journal:  HIV Med       Date:  2017-04-26       Impact factor: 3.180

5.  Sexual Behavior and Perceived HIV Risk Among HIV-Negative Members of Serodiscordant Couples in East Africa.

Authors:  Valentine Wanga; Jared M Baeten; Elizabeth A Bukusi; Nelly R Mugo; Stephen Asiimwe; Kenneth Ngure; Andrew Mujugira; Timothy Muwonge; Josephine B Odoyo; Jessica E Haberer; Connie Celum; Renee Heffron
Journal:  AIDS Behav       Date:  2020-07

6.  Effective use of pre-exposure prophylaxis (PrEP) Among stimulant users with multiple condomless sex partners: a longitudinal study of men who have sex with men in Los Angeles.

Authors:  David Goodman-Meza; Matthew R Beymer; Ryan M Kofron; K Rivet Amico; Christina Psaros; Lane R Bushman; Peter L Anderson; Robert Bolan; Wilbert C Jordan; James F Rooney; Amy R Wohl; Raphael J Landovitz
Journal:  AIDS Care       Date:  2019-03-20

7.  Making an Impact With Preexposure Prophylaxis for Prevention of HIV Infection.

Authors:  Jared M Baeten
Journal:  J Infect Dis       Date:  2016-07-14       Impact factor: 5.226

Review 8.  Delivering preexposure prophylaxis to pregnant and breastfeeding women in Sub-Saharan Africa: the implementation science frontier.

Authors:  Dvora L Joseph Davey; Linda-Gail Bekker; Pamina M Gorbach; Thomas J Coates; Landon Myer
Journal:  AIDS       Date:  2017-10-23       Impact factor: 4.177

Review 9.  Initiation, discontinuation, and restarting HIV pre-exposure prophylaxis: ongoing implementation strategies.

Authors:  Sarah E Rutstein; Dawn K Smith; Shona Dalal; Rachel C Baggaley; Myron S Cohen
Journal:  Lancet HIV       Date:  2020-08-27       Impact factor: 12.767

Review 10.  The preexposure prophylaxis revolution; from clinical trials to programmatic implementation.

Authors:  Nelly R Mugo; Kenneth Ngure; Michael Kiragu; Elizabeth Irungu; Nduku Kilonzo
Journal:  Curr Opin HIV AIDS       Date:  2016-01       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.